PhosphoDisco: A Toolkit for Co-regulated Phosphorylation Module Discovery in Phosphoproteomic Data

Tobias Schraink1, Lili Blumenberg2, Grant Hussey1

  • 1Division of Precision Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA; Institute for Systems Genetics, New York University Grossman School of Medicine, New York, New York, USA; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, New York, USA.

Insights

We developed PhosphoDisco to identify co-regulated phosphorylation sites, revealing new cancer signaling pathways. This tool aids in classifying tumors and personalizing cancer therapies based on active signaling cascades.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Kinases are crucial in cancer pathways and targeted by precision therapies.
  • Phosphoproteomics reveals kinase activity, identifying therapeutic targets and biomarkers.
  • Identifying co-regulated phosphorylation sites aids in understanding signaling pathways and therapeutic targets, but is experimentally limited.

Purpose of the Study:

  • To develop a computational toolkit, PhosphoDisco, for identifying co-regulated phosphorylation modules.
  • To address the challenge of defining functionally relevant co-regulated phosphorylation modules from phosphoproteomic data.
  • To apply PhosphoDisco to cancer phosphoproteomic data for discovering novel signaling pathways and therapeutic strategies.

Main Methods:

  • Developed PhosphoDisco, a computational toolkit for analyzing co-regulated phosphorylation sites.
  • Applied PhosphoDisco to tandem mass spectrometry-based phosphoproteomic data from breast and non-small cell lung cancer.
  • Utilized identified modules for pathway analysis and tumor classification based on signaling activity.

Main Results:

  • Identified canonical and putative novel phosphorylation site modules in breast and lung cancer datasets.
  • Discovered a new cell cycle checkpoint module significantly enriched in basal breast cancer.
  • Found a module of PRKC isozymes potentially co-regulated by CDK12 in lung cancer.

Conclusions:

  • PhosphoDisco effectively identifies co-regulated phosphorylation modules from phosphoproteomic data.
  • The identified modules offer insights into active signaling pathways in patient tumors.
  • PhosphoDisco facilitates personalized cancer treatment strategies and novel tumor classification based on signaling profiles.